Half the population.
Half their lives.
Still
no clear path to care.

InAWH unites global experts to turn evidence into better care for women in midlife.

Join us for InAWH’s Inaugural Convening

October 9, 2026

The Yale Club, New York City

Women's midlife health is finally getting attention and momentum. 

The gap between science and care is real, but it’s fixable now.  

On October 9, InAWH convenes the world's experts in midlife women's health to do something about it. 

Confirmed Speakers

Jill Angelo

Vice President, Women's Health and Commercial Partnerships, OURA

Dr. Elizabeth Cherot

CMO, Unified Women's Healthcare

Connie Collingsworth

Board Chair, InAWH · Former COO, Gates Foundation

Dr. John Eden

Reproductive Endocrinologist and Conjoint Associate Professor, UNSW Sydney

Dr. Annalisa Jenkins

Honorary Professor of Medicine, St Mary University

Dr. Orin S. Levine

President and CEO, Washington Research Foundation

Dr. Cecelia Lindgren

Executive VP Applied AI & Robotics, Ellison Institute

Dr. Mary Jane Minkin

Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine

Dr. Pauline Maki 

Professor of Psychiatry, Psychology and Obstetrics & Gynecology, University of Illinois 

Dr. Frida Polli 

Visiting Innovation Scholar, MIT 

Sreyna Rath 

CEO and Founder, Jaimee 

Anna Samuelsson 

Partner and Managing Director, Factory Capital 

Paula Schneider 

CEO, InAWH · Former President & CEO, Susan G. Komen 

Kyle Snook 

CEO, Axia Women's Health 

Dr. Welela Tereffe 

Former Chief Medical Officer, MD Anderson Cancer Center 

Event Details

  • Date  Friday, October 9, 2026 

  • Time  Doors at 8:30 a.m. | Program 9 a.m. to 3:30 p.m.

  • Location  The Yale Club, 50 Vanderbilt Avenue, New York, NY 10017 

It’s time to close a decades-old gap

Perimenopause and postmenopause span roughly half of every woman’s life. Yet research has been underfunded, care fragmented, and clinicians have received little or no training

This is the gap InAWH exists to close.

  • More than 450 million women worldwide are navigating perimenopause or menopause at any given time.

  • 58% of global medical textbooks contain no mention of menopause

  • Women live longer than men but spend 25% more of their lives in poor health

About InAWH

Two women smiling and talking outdoors, one with headphones around her neck, in black and white with a blue gradient overlay.

The primary constraint in women’s midlife health is no longer a lack of science alone. It is the failure to move evidence into practice - quickly, consistently, and at scale.

The Institute Advancing Women’s Health (InAWH) exists to shorten the distance between discovery and delivery. We turn credible, evidence-informed science into tools clinicians can use now: practical frameworks, care models, training pathways, and implementation-ready guidance that work in real-world settings.

Our focus is practice change. Our measure of success is better care, earlier intervention, and better health for women in midlife and beyond.

InAWH is designed to convert today’s momentum into measurable improvements in care.

Vision, Mission, Guiding Principles

InAWH is a global catalyst working to make evidence-based, cross-disciplinary midlife care the global standard. InAWH will meet the rising demand by uniting leading organizations and experts to develop science-based solutions that make credible women’s midlife health knowledge accessible to all.

Our Vision

A world where every woman has access to holistic, integrated midlife care that supports her dignity, vitality, and well-being.

Our Mission

To close the global gap between what science knows about women’s midlife health and how care is delivered.

Guiding Principles

Evidence-Based and Evidence-Informed

We are grounded in rigorous, credible, and evidence-informed science.

Multi-Disciplinary

We integrate insights from multiple clinical disciplines to address the interconnected nature of women’s health in midlife.

Informed by Women

We ground our work in women’s lived experiences to ensure relevance and meaningful impact.

Global and Diverse

We value perspectives across cultures, disciplines, and health systems.

Collaborative

We work with professional societies, health systems, and existing organizations to strengthen the broader ecosystem.

Impact-Focused

We prioritize work that leads to meaningful improvements in clinical practice, standards of care, and health outcomes.

Our People

InAWH is building a global team of leaders in medicine, research, and women’s health working to transform midlife care.

Management

Paula Schneider

Chief Executive Officer

Paula Schneider

InAWH CEO  ·  Former President and CEO of Susan G. Komen

As CEO of InAWH, Institute for Advancing Women’s Health, and previously President and CEO of Susan G. Komen, the world’s largest breast cancer organization, Schneider leads the mission to close the persistent gap between what science knows about women’s health and what women are actually experiencing in care.

Board of Directors

Connie Collingsworth

Connie Collingsworth

Board Chair, Former COO of the Gates Foundation

Dr. Annalisa Jenkins

Dr. Annalisa Jenkins

Honorary Professor Medicine, St Mary University

Anna Samuelsson

Anna Samuelsson

Partner and Managing Director, Factory Capital

Paula Schneider

Paula Schneider

InAWH CEO, Former President and CEO of Susan G. Komen

Medical Advisory Board

Dr. John Eden

Dr. John Eden, MB, BS, MD

Gynaecologist and Reproductive Endocrinologist, Conjoint Professor UNSW

Barbara Gulanski

Barbara Gulanski, MD, MPH

Endocrinologist and Board-Certified Internist, Yale University School of Medicine

Dr. Nicole Jaff

Dr. Nicole Jaff, PhD, MSCP

Board of Trustees, International Menopause Society

Cecilia M. Lindgren

Cecilia M. Lindgren, PhD, FMedSci

Executive VP Applied AI & Robotics, Ellison Institute; Visiting Professor, Oxford

Mary Jane Minkin

Mary Jane Minkin, MD, FACOG

Clinical Professor, Dept. of Obstetrics, Gynecology and Reproductive Sciences, Yale

Erica S. Spatz

Erica S. Spatz, MD, MHS

Associate Professor of Cardiology and Epidemiology, Yale University School of Medicine

Dr. Welela Tereffe

Welela Tereffe, MD, MPH, MHCM

Former Chief Medical Executive, The University of Texas MD Anderson Cancer Center